Recordati Industria Chimica E Farmaceutica (OTCMKTS:RCDTF) Sees Large Volume Increase – Here’s What Happened

Recordati Industria Chimica E Farmaceutica S.P.A. (OTCMKTS:RCDTF) saw an uptick in trading volume on Thursday. Approximately 750 shares changed hands during mid-day trading, an increase of 275% from the previous session’s volume of 200 shares. The stock last traded at $58.79 and had previously closed at $60.00.

Recordati Industria Chimica E Farmaceutica Stock Performance

The company has a market cap of $12.13 billion, a PE ratio of 20.97 and a beta of 0.26. The stock’s 50 day moving average is $58.03 and its 200-day moving average is $57.79. The company has a quick ratio of 0.86, a current ratio of 1.26 and a debt-to-equity ratio of 0.79.

Recordati Industria Chimica E Farmaceutica (OTCMKTS:RCDTF) last issued its quarterly earnings data on Wednesday, July 29th. The company reported $0.91 EPS for the quarter. Recordati Industria Chimica E Farmaceutica had a net margin of 18.38% and a return on equity of 33.73%. The business had revenue of $810.70 million during the quarter.

About Recordati Industria Chimica E Farmaceutica

Recordati Industria Chimica e Farmaceutica S.p.A. is an Italian pharmaceutical company focused on the research, development, manufacture and commercialization of medicines. Its activities are centered on specialty-care and rare-disease treatments, with products addressing areas such as endocrinology, oncology, urology, cardiology, gastroenterology and other specialized medical needs.

The company markets both proprietary and licensed medicines, serving patients through prescription products and therapies for uncommon or underserved conditions.